Release Date: 24/04/19 08:43 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 509.86KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%